You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Short report
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma

Authors

  • Rehana Hewavisenti Centenary Institute, Newtown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Angela Ferguson Centenary Institute, Newtown, New South Wales, Australia Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kevin Wang School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Deanna Jones Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Thomas Gebhardt Department of Immunology and Microbiology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Jarem Edwards Centenary Institute, Newtown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Mei Zhang Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia Department of Radiation Oncology, Chris O’Brien Lifehouse, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Warwick Britton Centenary Institute, Newtown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Jean Yang School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Angela Hong Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia Department of Radiation Oncology, Chris O’Brien Lifehouse, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Umaimainthan Palendira Centenary Institute, Newtown, New South Wales, Australia Infectious Diseases and Immunology, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles

Citation

Hewavisenti R, Ferguson A, Wang K, et al
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma
Journal for ImmunoTherapy of Cancer 2020;8:e000452. doi: 10.1136/jitc-2019-000452
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.